Feed:Trial Acronyms

From Wiki Journal Club
Jump to: navigation, search

{

  "trial_acronyms" : {
     "A-HeFT" : "African-American Heart Failure Trial",
     "SPARCL" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels",
     "RE-COVER" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism",
     "RALES" : "Randomized Aldactone Evaluation Study",
     "ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism",
     "TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban",
     "TRISS" : "Transfusion Requirements in Septic Shock",
     "TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome",
     "HEMO" : "Hemodialysis",
     "BEST" : "The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation",
     "ALBIOS" : "Albumin Italian Outcome Sepsis",
     "JUPITER" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin",
     "ESCAPE" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness",
     "PIONEER-HF" : "comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode",
     "ICAP" : "Evaluation of additive benefit of colchicine to conventional therapy in acute pericarditis",
     "ANNEXA" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors",
     "STAMPEDE" : "Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently",
     "EUROPA" : "European Trial on Reduction of Cardiac Events with Perindopril in Patients with Stable Coronary Artery Disease",
     "DPP" : "Diabetes Prevention Program",
     "WISDOM" : "Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management",
     "PCPT" : "Prostate Cancer Prevention Trial",
     "HEAT" : "Permissive Hyperthermia through Avoidance of Acetaminophen in Known or Suspected Infection in the Intensive Care Unit",
     "COPERNICUS" : "Carvedilol Prospective Randomized Cumulative Survival",
     "SCD-HeFT" : "Sudden Cardiac Death in Heart Failure Trial",
     "Look AHEAD" : "Look Action for HEAlth in Diabetes",
     "HEARTMATE II" : "Advanced heart failure treated with continuous-flow left ventricular assist device",
     "CABANA" : "Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation",
     "RE-LY" : "Randomized Evaluation of Long-Term Anticoagulation Therapy",
     "TREAT" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy",
     "SPYRAL HTN-ON MED" : "Global Clinical Study of Renal Denervation With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy",
     "SYNTAX" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery",
     "PIOPED II" : "Prospective Investigation of Pulmonary Embolism Diagnosis II",
     "EUCLID" : "Examining use of ticagrelor in peripheral artery disease",
     "COAPT" : "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation",
     "Oscillate" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early",
     "ATLAS" : "Adjuvant Tamoxifen: Longer Against Shorter",
     "IDEAL-ICU" : "Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit",
     "DIVA" : "Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty",
     "TIMACS" : "The Timing of Intervention in Acute Coronary Syndromes",
     "NINDS" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study",
     "PARADIGM-HF" : "Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure",
     "TRITON-TIMI 38" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38",
     "HYVET" : "Hypertension in the Very Elderly Trial",
     "PRORATA" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients",
     "PROFESS" : "Prevention Regimen for Effectively Avoiding Second Strokes",
     "CANTOS" : "Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)",
     "TALC" : "Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid",
     "NORSTENT" : "Drug-Eluting or Bare-Metal Stents for Percutaneous Coronary Intervention in Stable or Unstable Coronary Artery Disease",
     "CHOIR" : "Correction of Hemoglobin and Outcomes in Renal Insufficiency",
     "BASALT" : "Best Adjustment Strategy for Asthma in the Long Term",
     "SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial",
     "POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm",
     "POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial",
     "CvLPRIT" : "Complete Versus Lesion-Only Primary PCI Trial",
     "CATIE" : "Clinical Antipsychotic Trials of Intervention Effectiveness",
     "ACCORD BP" : "ACCORD Study Group",
     "FAME 2" : "FFR vs. Angiographyfor Multivessel Evaluation 2",
     "ARDSNet" : "Acute Respiratory Distress Syndrome Network",
     "OVIVA" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection",
     "ProCESS" : "Protocolized Care for Early Septic Shock",
     "ADVANCE" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation",
     "ARISE" : "Australasian Resuscitation in Sepsis Evaluation",
     "CREST" : "Carotid Revascularization Endarterectomy vs. Stenting Trial",
     "SPACE" : "Strategies for Prescribing Analgesics Comparative Effectiveness",
     "DOSE" : "Diuretic Optimization Strategies Evaluation",
     "PROSEVA" : "Proning Severe ARDS Patients",
     "WASID" : "Warfarin-Aspirin Symptomatic Intracranial Disease",
     "SAFE" : "Saline versus Albumin Fluid Evaluation",
     "MADIT-CRT" : "Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy",
     "POET" : "Partial Oral Treatment of Endocarditis",
     "SPS3-BP" : "Secondary Prevention of Small Subcortical Strokes-Blood Pressure",
     "CHANCE" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events",
     "CORTICUS" : "Corticosteroid Therapy of Septic Shock",
     "UKPDS" : "United Kingdom Prospective Diabetes Study",
     "AIRTRIP" : "AnakInRa for Treatment of Recurrent Idiopathic Pericarditis",
     "AFFIRM" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management",
     "EINSTEIN CHOICE" : "Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism",
     "COURAGE" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation",
     "AVOID" : "Comparing Oxygen with normal air in patients with ST-Segment Elevation Myocardial Infarction who are not hypoxic.",
     "SAVE" : "Survival and Ventricular Enlargement Trial",
     "PIONEER AF-PCI" : "Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with AF who Undergo Percutaneous Coronary Intervention",
     "BLOCK-HF" : "Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block",
     "NASCET" : "North American Symptomatic Carotid Endarterectomy Trial",
     "CAPRICORN" : "Carvedilol Post-Infarct Survival Control in LV Dysfunction",
     "ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group",
     "CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2",
     "CHOICE" : "CHOICE is not an abbreviation per a communication with the research team",
     "SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism",
     "AMPLIFY" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy",
     "PRECISION" : "Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen",
     "AIDA" : "Amsterdam Investigator-Initiated Absorb Strategy All-Comers Trial",
     "V-HeFT" : "Vasodilator Heart Failure Trial",
     "EPCAT II" : "Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty II",
     "TTM" : "Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest",
     "COGENT" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial",
     "COMMIT/CCS-2" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study",
     "GUSTO" : "Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries",
     "SOCRATES" : "Ticagrelor versus aspirin in stroke/TIA",
     "PROWESS-SHOCK" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock",
     "HOPE" : "Heart Outcomes Prevention Evaluation",
     "AVERROES" : "Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment",
     "HACA" : "Hypothermia After Cardiac Arrest",
     "CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance",
     "RAVE" : "Rituximab in ANCA-Associated Vasculitis",
     "IDNT" : "Irbesartan Diabetic Nephropathy Trial",
     "SOAP II" : "Sepsis Occurrence in Acutely Ill Patients II",
     "MERIT-HF" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure",
     "NSABP B-32" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32",
     "CLOSURE I" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale",
     "RAFT" : "Resynchronization–Defibrillation for Ambulatory Heart Failure",
     "SPAF" : "Stroke Prevention in Atrial Fibrillation",
     "TRIUMPH" : "Transfusion Reduction Efficacy and Safety Clinical Investigation, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria",
     "VADT" : "Veterans Affairs Diabetes Trial",
     "PREPIC 2" : "Prevention du Risque d'Embolie Pulmonaire par Interruption Cave 2",
     "MOMENTUM 3" : "Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3",
     "ERSPC" : "European Randomized Study of Screening for Prostate Cancer",
     "PREPIC" : "Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group",
     "TRICC" : "Transfusion Requirements in Critical Care",
     "REDUCE-IT" : "Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial",
     "REDUCE" : "Reduction in the Use of Corticosteroids in Exacerbated COPD",
     "HERA" : "Herceptin Adjuvant Trial",
     "BARI 2D" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes",
     "DANISH" : "Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality",
     "DANAMI-3 PRIMULTI" : "Third Danish Study of Optimal Acute Treatment of Patients with STEMI: Primary PCI in Multivessel Disease",
     "PANTER" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis",
     "RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure",
     "ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial",
     "EDIC" : "Epidemiology of Diabetes Interventions and Complications",
     "RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan",
     "FAIR-HF" : "IV Iron for Symptoms in Patients with HFrEF and Iron Deficiency",
     "Blood-Pressure Reduction in Black Barbershops" : "Blood-Pressure Reduction in Black Barbershops",
     "StiL" : "Study Group Indolent Lymphomas",
     "RESCUEicp" : "Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure",
     "ALLHAT" : "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial",
     "CLOT" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism",
     "TRICS III" : "Transfusion Requirements in Cardiac Surgery",
     "ISIS-2" : "Second International Study of Infarct Survival",
     "BeSt" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)",
     "PROVE IT-TIMI 22" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22",
     "EVEREST" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan",
     "CULPRIT-SHOCK" : "Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock",
     "NETT" : "National Emphysema Treatment Trial",
     "APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban",
     "MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk",
     "TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist",
     "DAPT" : "Dual Antiplatelet Therapy",
     "SPS3-Clopidogrel+ASA" : "Secondary Prevention of Small Subcortical Strokes clopidogrel+ASA",
     "CARRESS-HF" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure",
     "DASH" : "Dietary Approaches to Stop Hypertension",
     "MUSTT" : "Multicenter Unsustained Tachycardia Trial",
     "WOSCOPS" : "West of Scotland Coronary Prevention Study",
     "OASIS-5" : "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes",
     "V-HeFT II" : "Vasodilator Heart Failure Trial II",
     "FACTT" : "Fluids and Catheters Treatment Trial",
     "CIRT" : "Cardiovascular Inflammation Reduction Trial",
     "SOLVD" : "Studies of Left Ventricular Dysfunction",
     "MSH" : "Multicenter Study of Hydroxyurea in Sickle-Cell Anemia",
     "iPrEx" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")",
     "ORBIT-AF" : "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation",
     "EXTRA" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma",
     "EMBRACE" : "30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event",
     "SPRINT" : "Systolic Blood Pressure Intervention Trial",
     "iFR-SWEDEHEART" : "Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome",
     "CAST I" : "Cardiac Arrhythmia Suppression Trial",
     "LESS" : "Lumbar Epidural Steroid Injections for Spinal Stenosis",
     "RESPECT" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment",
     "FEAST" : "Fluid Expansion as Supportive Therapy",
     "TNT" : "Treating to New Targets",
     "DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients",
     "CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events",
     "IRONOUT-HF" : "Iron Repletion Effects on Oxygen Uptake in Heart Failure",
     "ACOSOG Z0011" : "The American College of Surgeons Oncology Group (ACOSOG) Z0011",
     "MADIT-II" : "Multicenter Automatic Defibrillator Implantation Trial II",
     "AATAC" : "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device",
     "TIPPS" : "Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia",
     "DCCT" : "Diabetes Control and Complications Trial",
     "4S" : "Scandinavian Simvastatin Survival Study",
     "ONTARGET" : "Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial",
     "ACCORD Lipid" : "Action to Control Cardiovascular Risk in Diabetes-Lipid",
     "PEITHO" : "Pulmonary Embolism Thrombolysis trial",
     "EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study",
     "LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results",
     "MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin",
     "PROTECT AF" : "WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation",
     "CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections",
     "STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression",
     "EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)",
     "FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease",
     "AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients",
     "CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer",
     "EVOLVE" : "Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis",
     "FAME" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation",
     "CHARM-Preserved" : "Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved",
     "ACURASYS" : "ARDS et Curarisation Systematique",
     "ADJUST-PE" : "Age aDJUSTed D-Dimer to rule out PE",
     "DETO2X-AMI" : "Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction",
     "MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients",
     "PREDIMED" : "Prevención con Dieta Mediterránea",
     "PLATO" : "Platelet Inhibition and Patient Outcomes",
     "ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention",
     "ART" : "Arterial Revascularization Trial",
     "IRIS" : "International Randomized Study of Interferon and STI571",
     "ASCEND" : "Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis",
     "VANISH" : "Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs",
     "ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial",
     "ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock",
     "ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation",
     "PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis",
     "ENGAGE AF-TIMI 48" : "Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48",
     "CAMERA" : "Computer Assisted Management in Early Rheumatoid Arthritis",
     "COMPASS" : "Cardiovascular Outcomes for People Using Anticoagulation Stratgies",
     "STAR" : "Study of Tamoxifen and Raloxifene (NSABP P-2)",
     "MPACT" : "Metastatic Pancreatic Adenocarcinoma Clinical Trial",
     "DONATE HCV" : "Donors of Hepatitis C NAT Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients",
     "PARTNER A" : "Placement of Aortic Transcatheter Valves, Cohort A",
     "SHIFT" : "Systolic Heart failure treatment with the If inhibitor ivabradine Trial",
     "SONIC" : "Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease",
     "MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering",
     "NCDS" : "The National Cooperative Dialysis Study",
     "ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events",
     "SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam",
     "TRED-HF" : "Treatment for heart failure in patients with recovered dilated cardiomyopathy",
     "GISSI-3" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico",
     "PRAMI" : "Preventative Angioplasty in Acute Myocardial Infarction",
     "RACE II" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II",
     "AURORA" : "A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events",
     "IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II",
     "PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A",
     "LoDoCo" : "Low-Dose Colchicine",
     "CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition",
     "NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design",
     "ASPREE" : "Aspirin in Reducing Events in the Elderly",
     "RE-ALIGN" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement",
     "CANVAS" : "Canagliflozin Cardiovascular Assessment Study",
     "SEPSISPAM" : "Sepsis and Mean Arterial Pressure",
     "AKIKI" : "Artificial Kidney Initiation in Kidney Injury",
     "ALMS" : "Aspreva Lupus Management Study",
     "ECST" : "European Carotid Surgery Trial",
     "DEFINITE" : "Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation",
     "WHI E+P" : "Women's Health Initiative Estrogen and Progestin Trial",
     "RE-DUAL PCI" : "Randomized evaluation of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin in patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention",
     "HPS2-THRIVE" : "Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events",
     "COMET" : "Carvedilol Or Metoprolol European Trial",
     "NSABP P-1" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1",
     "VASST" : "Vasopressin and Septic Shock Trial",
     "IALT" : "International Adjuvant Lung Cancer Trial",
     "EMILIA" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer",
     "WOEST" : "What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing",
     "ATLAS ACS 2-TIMI 51" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51",
     "RELAX" : "Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction",
     "ACCORD" : "Action to Control Cardiovascular Risk in Diabetes",
     "VA NEPHRON-D" : "Veterans Affairs Nephropathy in Diabetes",
     "Val-HeFT" : "Valsartan Heart Failure Trial",
     "CRISTAL" : "Colloids Versus Crystalloids for the Resuscitation of the Critically Ill",
     "MIND-USA" : "Modifying the Impact of ICU-Associated Neurological Dysfunction–USA",
     "CATT" : "Comparison of Age-Related Macular Degeneration Treatment Trails",
     "PRODIGE 4 ACCORD 11" : "PRODIGE 4 Actions concertées dans les Cancers COloRectaux et Digestifs",
     "EDS" : "European Dexamethasone Study",
     "SUP-ICU" : "Stress Ulcer Prophylaxis in the Intensive Care Unit",
     "ROCKET AF" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation",
     "ECASS III" : "European Cooperative Acute Stroke Study III",
     "NLST" : "National Lung Screening Trial",
     "SALT-ED" : "Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department",
     "ISAR-TRIPLE" : "Triple therapy in Patients who Require Oral Anticoagulation After Drug-Eluting Stent Implantation",
     "ADRENAL" : "Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock",
     "MASS" : "Multicentre Aneurysm Screening Study",
     "IMPROVE-IT" : "IMProved Reduction of Outcomes: Vytorin Efficacy International Trial",
     "POP-UP" : "Pantoprazole or Placebo for Stress Ulcer Prophylaxis",
     "BRIDGE" : "Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for Elective Invasive Procedure or Surgery",
     "PESIT" : "Pulmonary Embolism in Syncope Italian Trial",
     "CURE" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events",
     "FOCUS" : "Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair",
     "CASTLE-AF" : "Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation",
     "ORBITA" : "Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina",
     "ATN" : "Acute Renal Failure Trial Network Study",
     "TORCH" : "Towards a Revolution in COPD Health",
     "ANNEXA-4" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors",
     "TONE" : "Trial of Nonpharmacologic Interventions in the Elderly",
     "STOPAH" : "Steroids or Pentoxifylline for Alcoholic Hepatitis",
     "REMATCH" : "Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure",
     "BICAR-ICU" : "Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill: A Multiple Center Randomized Clinical Trial",
     "AAPAC" : "Appendicitis Acuta",
     "MIDA" : "Mitral Regurgitation International Database",
     "VALIANT" : "Valsartan in Acute Myocardial Infarction Trial",
     "UKPDS 34" : "UK Prospective Diabetes Study 34",
     "BRIM-3" : "BRAF Inhibitor in Melanoma 3",
     "PARTNER B" : "Placement of Aortic Transcatheter Valves, Cohort B",
     "CYTO-PV" : "Cytoreductive Therapy in Polycythemia Vera",
     "AMPLIFY-EXT" : "Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment",
     "FLAME COPD" : "Effect of Indacaterol Glycopyronium Vs. Fluticasone Salmeterol on COPD Exacerbations",
     "CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study",
     "STICH" : "Surgical Treatment for Ischemic Heart Failure",
     "ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade",
     "ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial",
     "ASTRAL" : "Angioplasty and Stenting for Renal Artery Lesions",
     "DIG" : "Digitalis Investigation Group",
     "FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke",
     "METEOR" : "Meniscal Tear in Osteoarthritis Research",
     "RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes",
     "CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure",
     "AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure",
     "NOTT" : "Nocturnal Oxygen Therapy Trial",
     "WARFASA" : "Warfarin and Aspirin",
     "IDEAL" : "Initiating Dialysis Early and Late",
     "SADHAT" : "Sertraline Antidepressant Heart Attack Randomized Trial",
     "CATIE-AD" : "Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease",
     "MOPETT" : "Moderate Pulmonary Embolism Treated with Thrombolysis",
     "NICE-SUGAR" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation",
     "ACTIVE A" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events",
     "NEAT-HFpEF" : "Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction",
     "ELITE-Symphony" : "Efficacy Limiting Toxicity Elimination-Symphony",
     "IST" : "International Stroke Trial",
     "ATTRACT" : "Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis",
     "FOURIER" : "Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk",
     "DODS" : "D-dimer Optimal Duration Study",
     "ACCOMPLISH" : "Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension",
     "HPTN 052" : "HIV Prevention Trials Network 052 Study",
     "SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement",
     "EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure",
     "POISE" : "PeriOperative ISchemic Evaluation",
     "UPLIFT" : "Understanding Potential Long-Term Impacts on Function with Tiotropium",
     "CSG Captopril Trial" : "Collaborative Study Group Captopril Trial",
     "ODYSSEY LONG TERM" : "Long-term Safety and Tolerability of Alirocumab in High Cardiovascular Risk Patients with Hypercholesterolemia Not\nAdequately Controlled with Their Lipid Modifying Therapy",
     "SHOCK" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK"
  }

}